| First Author | Zhou T | Year | 2022 |
| Journal | Cell Death Dis | Volume | 13 |
| Issue | 12 | Pages | 1056 |
| PubMed ID | 36539414 | Mgi Jnum | J:333696 |
| Mgi Id | MGI:7411576 | Doi | 10.1038/s41419-022-05433-0 |
| Citation | Zhou T, et al. (2022) IL-4 induces reparative phenotype of RPE cells and protects against retinal neurodegeneration via Nrf2 activation. Cell Death Dis 13(12):1056 |
| abstractText | Retinal degeneration is a kind of neurodegeneration characterized by progressive neuronal death and dysfunction of retinal pigment epithelium (RPE) cells, leading to permanent visual impairment. It still lacks effective therapeutic options and new drugs are highly warranted. In this study, we found the expression of IL-4, a critical regulator of immunity, was reduced in both patients and mouse models. Importantly, exogenous intravitreal IL-4 application could exert a novel neuroprotective effect, characterized by well-preserved RPE layer and neuroretinal structure, as well as amplified wave-amplitudes in ERG. The RNA-seq analysis revealed that IL-4 treatment suppressed the essential oxidative and pro-inflammatory pathways in the degenerative retina. Particularly, IL-4 upregulated the IL-4Ralpha on RPE cells and induced a reparative phenotype via the activation of Nrf2 both in vitro and in vivo. Furthermore, the Nrf2-/- mice displayed no recovery in response to IL-4 application, highlighting a significant role of Nrf2 in IL-4-mediated protection. Our data provides evidence that IL-4 protects against retinal neurodegeneration by its antioxidant and anti-inflammatory property through IL-4Ralpha upregulation and Nrf2 activation in RPE cells. The IL-4/IL-4Ralpha-Nrf2 axis maybe the potential targets for the development of novel therapies for neurodegenerative diseases. |
